SKBA Capital Management’s Dentsply Sirona XRAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$13.4M Buy
1,154,450
+3,710
+0.3% +$46.3K 1.84% 22
2025
Q4
$13.2M Buy
1,150,740
+10,310
+0.9% +$121K 1.87% 25
2025
Q3
$14.5M Buy
1,140,430
+142,900
+14% +$2.07M 2% 15
2025
Q2
$15.8M Buy
997,530
+340,940
+52% +$5.1M 2.28% 12
2025
Q1
$9.81M Buy
656,590
+125,000
+24% +$2.21M 1.46% 34
2024
Q4
$10.1M Buy
+531,590
New +$11.2M 1.59% 25

Other funds holding XRAY

SKBA Capital Management's XRAY Position: Q1 2026 in Review

SKBA Capital Management increased its Dentsply Sirona (XRAY) stake by 0.32% in Q1 2026, buying an estimated $46.3K and bringing the position to 1,154,450 shares worth $13.4M. The position accounts for 1.84% of the portfolio, ranked #22.

SKBA Capital Management first reported a position in XRAY in Q4 2024 and has held it in 6 quarters since. The position peaked at $15.8M in Q2 2025. 382 funds tracked by Wall St. Rank hold XRAY as of Q1 2026.

  • SKBA Capital Management held 1,154,450 shares of Dentsply Sirona worth $13.4M as of Q1 2026.
  • SKBA Capital Management bought 3,710 Dentsply Sirona shares in Q1 2026, an estimated $46.3K.
  • Dentsply Sirona made up 1.84% of SKBA Capital Management's portfolio in Q1 2026, its #22 holding.
  • SKBA Capital Management first reported a position in Dentsply Sirona in Q4 2024 and has held it in 6 quarters since.
  • SKBA Capital Management's Dentsply Sirona position peaked at $15.8M in Q2 2025.
  • 382 funds tracked by Wall St. Rank held Dentsply Sirona as of Q1 2026.

Based on SKBA Capital Management's 13F filing for Q1 2026, filed 13 May 2026.